In this interview we talk to Stephane Moreau (Shimadzu, Europe) about his research into nSMOL monoclonal antibody analysis. Stephane discusses the benefits of this technique in comparison with traditional technology like immunoassays.
In this interview we talk to John Kolman (QPS, DE, USA) about his hopes for the future of human health care. John highlights the next steps for QPS and how important it is to be adaptive and attentive to new clients and regulations. He also discusses where he think the field will be in 5 years time and the advice he would give to a young scientist.
As the 2017 BOSCA winner, we spoke to Dr Henion about some of the most groundbreaking and pivotal moments in his career.
Who are the people behind the science? We interviewed key experts to uncover who their bioanalytical hero is. In this series we sit down with Chad Briscoe (PRA Health Sciences), Joy Concepcion (Gyros Protein Technologies), Caitlin Dunning (Waters Corporation), Mike Godeny (Merck KGaA), Sankeetha Nadarajah (Bioanalysis), Steve Piccoli (WRIB), Nikunj Tanna (Waters Corporation) and Amanda Wilson (Astrazeneca).
In this interview we talk to Candace Price (Merck KGaA, Darmstadt, Germany) about her current research focusing on the BioSPME technique. She goes on to discuss the advatanges of BioSPME compared to traditional sample preparation techniques, the possible future of the technique and how Merck KGaA introduce new technologies.
Drug-target complex specific antibodies: In this interview we talk to Michael Schwenkert (Bio-Rad Laboratories) about the poster he presented at EBF 2017.
We interviewed key experts to uncover their career highlights, what they love the most about their jobs and what advice they would give to their younger self. In this series we sit down with Chad Briscoe (PRA Health Sciences), Joy Concepcion (Gyros Protein Technologies), Caitlin Dunning (Waters Corporation), Mike Godeny (Merck KGaA), Sankeetha Nadarajah (Bioanalysis), Steve Piccoli (WRIB), Nikunj Tanna (Waters Corporation) and Amanda Wilson (Astrazeneca).
In order to explore further the underlying aspects of the results from our previous survey, we followed up with experts from Pharma backgrounds. Now, the results are in and we have put together an infographic of the results.
For our Spotlight on emerging technologies, we spoke to Scott Summerfield (GSK) about some of the technologies emerging in the bioanalytical field, the advantages and challenges faced with these techniques, and the scope for these technologies to advance further.
In this conference report we discuss our highlights from the 10th Open Meeting of the European Bioanalytical Forum – a New Journey begins (Barcelona, Spain; 14–17 November).